Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katharina van Baal has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    General practitioners’ involvement in oncological aftercare (ACTION): a study protocol for a mixed-methods study

    by Katharina van Baal, Stephanie Stiel, Svenja Arendt, Catharina Münte, Malte Klemmt

    Background: The growing number of cancer survivors in Germany necessitates sustainable, interdisciplinary aftercare. General practitioners (GPs) are well-positioned to provide long-term, trust-based support, including early detection of recurrences and late effects. However, evidence on the level of GP involvement in oncological aftercare, on interdisciplinary aftercare models involving GPs and specialists, and on associated barriers and facilitators remains limited. Methods: The project “general practitioners’ involvement in oncological aftercare” (ACTION; funded by the German Cancer Aid; grant number 70116960) will employ a mixed-methods approach across two phases. In phase 1, experiences with GPs involvement in oncological aftercare will be examined. Therefore, routine data from the AOK Lower Saxony and the Lower Saxony Cancer Registry will be analysed retrospectively (WP1a), supplemented by surveys of GPs (WP1b) and oncologists (WP1c), and qualitative interviews with patients (WP1d). Phase 2 will then build on the results from phase 1 to develop and agree on recommendations for GP involvement in oncological aftercare. An expert workshop will aim to develop structured recommendations for enhanced GP involvement (WP2a), which are refined via a Delphi consensus process (WP2b). Discussion: The ACTION project will generate new insights into the involvement of GPs in oncological aftercare and contribute to adequately addressing future challenges in patient care. It will stimulate the empirically supported development and implementation of interdisciplinary aftercare models in clinical practice and has thus the chance to improve the long-term care of cancer survivors in Germany. Trial registration: The study was registered with the German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS00040034; date of registration: 11 May 2026).

  • Open Access

    The ADAPT-HEAT Study: A Multi-Method Approach to Develop Recommendations for Drug Safety During Hot Weather (The CALOR List)—Study Protocol

    by Maxie Bunz, Pascal Nohl-Deryk, Heike van de Sand, Katharina van Baal, Svenja Arendt, Alina Herrmann, Ingo Meyer, Adriana Poppe, Olaf Krause, Johannes Heck, et al.

    Certain medications may adversely affect health during hot days and heatwaves by altering chronic conditions, comorbidities, fluid balance, or impairing heat adaptation. This study aims to develop evidence-based cross-sectoral recommendations for the safe administration of heat-sensitive medications, compiled into a so-called ‘CALOR’ list (calor: Latin for ‘heat’). Development of the CALOR list will follow a four-pillar process. First, a scoping review of scientific literature and best practices will identify potentially inadequate medications during heat events (heat-PIMs) and adaptation measures, resulting in a first draft. Second, an expert panel will refine this draft through a Delphi process to reach consensus on clinically relevant recommendations. Third, German statutory health insurance (SHI) claims data will be analysed to determine heat-PIMs prevalence; data from Cologne residents will additionally be linked with climate data to investigate health outcomes during heat events. Fourth, thirty health professionals (i.e., medical doctors, nurses, pharmacists) will field-test the CALOR list in summer, providing qualitative feedback on feasibility, leading to further refinement of the CALOR list. To our knowledge this study protocol presents the first study attempting to collate a comprehensive and actionable list of recommendations for drug safety management during hot days and heatwaves.

  • Open Access

    Perspectives, Action Strategies, and Approaches for Climate-Resilient and Low-Greenhouse-Gas Healthcare

    by Fabian Baum, Katharina van Baal, Jobst Augustin, Heike van de Sand, Klara Lorenz-Dant, Christina Lindemann, Dorothea Baltruks, Christa Büker, Johannes Deutschbein, Karin Geffert, et al.

    The impact of climate change on human health, healthcare, and health systems constitute one of the most pressing challenges of our time. In response, this position paper outlines perspectives, strategic approaches, and potential solutions aimed at fostering a climate-resilient and low-carbon healthcare sector. It was developed in collaboration with representatives from scientific societies, working groups, professional associations, and institutions with a dedicated expertise on the topic and was the subject of extensive interdisciplinary dialogue. This position paper reflects the outcome of a broad consensus-building process involving stakeholders from diverse academic and professional backgrounds. While it does not claim to be exhaustive, it represents the current state of discussions. The paper addresses six central topics: (1) Transformative research, (2) Research funding and research networking, (3) Data access and linkage, (4) Education and information opportunities, (5) Prevention, mitigation, and adaptation, as well as (6) Sustainability and climate neutrality in the health and research sector. The position paper advocates for intensified collaboration, courage and willingness to make decisions on the part of the scientific community, policymakers, and civil society to develop a future-proof and resilient healthcare system capable of withstanding the multifaceted challenges posed by climate change. This position paper is intended as a foundation for ongoing discourse and the development of concrete policy and practice-oriented strategies to enhance climate resilience and sustainability in health systems over the long term.

  • Open Access

    Qualitative process evaluation of a new short-hospital-stay model with a general medicine focus in Germany (STATAMED): Study protocol

    by Katharina van Baal, Juliane Poeck, Clarissa Maria Lemmen, Wiebke Böhne, Johannes Jahn, Eva-Maria Wild, Nils Schneider

    Background: The increasing number of elderly and multimorbid patients in need of care, coupled with a shortage of skilled health care professionals, poses significant challenges, especially in structurally underserved regions. STATAMED (funded by the G-BA Innovation Fund, 01NVF22103) represents a novel cross-sector care model emphasising short hospital stays with a general medicine focus for patients with (sub-)acute treatment needs. The intervention provides targeted, short-term inpatient care within STATAMED units, followed by rapid discharge and subsequent follow-up care in familiar environments. Key objectives include reduced emergency department visits, hospital stays and re-admissions, as well as the provision of needs-oriented health care. The broader evaluation comprises multiple quantitative and qualitative sub-studies. The present sub-study involves a qualitative process evaluation investigating the factors influencing acceptance, the degree of implementation and the impact on daily workflows and care structures at STATAMED sites. Methods: The sub-study will employ a combination of qualitative health services research methods (i.e., focus group discussions, individual interviews, participatory observations, discussion and information forums) to capture the perspectives and experiences of three main stakeholder groups: (1) patients and their relatives, (2) health care providers and (3) the general population. Data collected through protocols and transcripts will undergo qualitative content analysis to identify recurring themes and insights. Discussion: This sub-study seeks to elucidate the expectations, attitudes and needs of stakeholders, while assessing overall acceptance of the STATAMED model. Additionally, it aims to identify both facilitators and barriers to implementation, as well as the implications for work processes, collaboration and communication within daily care. The findings will inform strategies to optimise implementation, ensuring a successful transition to routine care. Given the political and public sensitivity surrounding health care system redesigns, particularly in rural areas, diverse stakeholder perspectives are incorporated. Trial registration: The study was registered with the German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS00033801; date of registration: 22 March 2024).


  • Open Access

    The implementation of guidelines in palliative care – a scoping review

    by Alexandra Ernst, Franziska Schade, Stephanie Stiel, Katharina van Baal, Franziska A. Herbst

    Background: Guidelines are essential tools for ensuring high-quality healthcare. However, discrepancies exist between their availability and practical implementation. In the context of palliative care, the extent to which guidelines are implemented and the barriers and facilitators that influence this process remain unknown. Aim: The present study aimed at systematically reviewing the international literature on the implementation of palliative care guidelines to evaluate factors that support or hinder implementation of palliative care guidelines globally. Method: A scoping review was conducted following the methodological approach of Arksey and O’Malley (2005). After the formulation of research questions and development of a search string, relevant studies investigating the implementation of guidelines were identified and retrieved from the databases CINAHL, LIVIO, PubMed and Web of Science Core Collection on 4 January 2024. Two researchers independently selected articles for inclusion, employing a blinded process with predefined inclusion and exclusion criteria. The results were subsequently categorised deductively by the same researchers using Petermann’s (2014) taxonomy of implementation outcomes. The results were summarised and presented in tabular form. Results: The search yielded 2,086 records, of which 1,252 were included in the title and abstract screening. Subsequently, 113 full-text articles were reviewed for eligibility, resulting in 29 articles deemed suitable for the final analysis. Six implementation outcomes were identified in the included literature: (1) acceptability (n = 15 articles), (2) adoption (n = 6 articles), (3) appropriateness (n = 9 articles), (4) feasibility (n = 9 articles), (5) fidelity/adherence (n = 14 articles) and (6) penetration (n = 14 articles). The majority of studies employed quantitative approaches (n = 22) and considered the perspective of healthcare professionals and their opinions regarding guideline implementation in palliative care. Only 4 articles considered patient related outcomes or the perspectives of the family caregivers. Ten articles reported on facilitators and barriers. Facilitators included healthcare professionals’ motivation and managerial support, while barriers primarily referred to time constraints and limited knowledge. Conclusions: Guideline implementation in palliative care is highly variable. Future research should aim at comprehensively analysing facilitators of and barriers to this process, considering diverse implementation outcomes. For these evaluations, mixed-method approaches are recommended.


  • Open Access

    End-of-life care in Germany between 2016 and 2020 – A repeated cross-sectional analysis of statutory health insurance data

    by Katharina van Baal, Melissa Hemmerling, Jona Theodor Stahmeyer, Stephanie Stiel, Kambiz Afshar

    The Hospice and Palliative Care Act of 2015 aimed at developing and regulating the provision of palliative care (PC) services in Germany. As a result of the legal changes, people with incurable diseases should be enabled to experience their final stage of life including death according to their own wishes. However, it remains unknown whether the act has impacted end-of-life care (EoLC) in Germany. The present study examined trends in EoLC indicators for patients who died between 2016 and 2020, in the context of Lower Saxony, Germany. Repeated cross-sectional analysis was conducted on data from the statutory health insurance fund AOK Lower Saxony (AOK-LS), referring to the years 2016–2020. EoLC indicators were: (1) the number of patients receiving any form of outpatient PC, (2) the number of patients receiving generalist outpatient PC and (3) specialist outpatient PC in the last year of life, (4) the onset of generalist outpatient PC and (5) the onset of specialist outpatient PC before death, (6) the number of hospitalisations in the 6 months prior to death and (7) the number of days spent in hospital in the 6 months prior to death. Data for each year were analysed descriptively and a comparison between 2016 and 2020 was carried out using t-tests and chi-square tests. Data from 160,927 deceased AOK-LS members were analysed. The number of patients receiving outpatient PC remained almost consistent over time (2016 vs. 2020 p = .077). The number of patients receiving generalist outpatient PC decreased from 28.4% (2016) to 24.5% (2020; p < .001), whereas the number of patients receiving specialist outpatient PC increased from 8.5% (2016) to 11.2% (2020; p < .001). The onset of generalist outpatient PC moved from 106 (2016) to 93 days (2020; p < .001) before death, on average. The onset of specialist outpatient PC showed the reverse pattern (2016: 55 days before death; 2020: 59 days before death; p = .041). Despite growing needs for PC at the end of life, the number of patients receiving outpatient PC did not increase between 2016 and 2020. Furthermore, specialist outpatient PC is being increasingly prescribed over generalist outpatient PC. Although the early initiation of outpatient PC has been proven valuable for the majority of people at the end of life, generalist outpatient PC was not initiated earlier in the disease trajectory over the study period, as was found to be true for specialist outpatient PC. Future studies should seek to determine how existing PC needs can be optimally met within the outpatient sector and identify factors that can support the earlier initiation of especially generalist outpatient PC. The study “Optimal Care at the End of Life” was registered in the German Clinical Trials Register (DRKS00015108; 22 January 2019).


  • Open Access

    End-of-life care in Germany between 2016 and 2020 – A repeated cross-sectional analysis of statutory health insurance data

    by Katharina van Baal, Melissa Hemmerling, Jona Theodor Stahmeyer, Stephanie Stiel, Kambiz Afshar

    Background The Hospice and Palliative Care Act of 2015 aimed at developing and regulating the provision of palliative care (PC) services in Germany. However, it remains unknown whether the act has impacted end-of-life care (EoLC) in Germany. Objective The present study examined trends in EoLC indicators between 2016–2020, in the context of Lower Saxony, Germany. Methods Repeated cross-sectional analysis was conducted on data from the statutory health insurance fund AOK Lower Saxony (AOK-LS), referring to the years 2016–2020. EoLC indicators were: (1) the number of patients receiving any form of outpatient PC, (2) the number of patients receiving generalist outpatient PC and (3) specialist outpatient PC in the last year of life, (4) the onset of generalist outpatient PC and (5) the onset of specialist outpatient PC before death, (6) the number of hospitalisations in the 6 months prior to death and (7) the number of days spent in hospital in the 6 months prior to death. Data for each year were analysed descriptively and a comparison between 2016 and 2020 was carried out using t-tests and chi-square tests. Results Data from 160,927 deceased AOK-LS members were analysed. The proportion of patients receiving outpatient PC remained consistent over time (2016 vs. 2020 p = 0.077). The number of patients receiving generalist outpatient PC decreased from 28.4% (2016) to 24.5% (2020; p < .001), whereas the number of patients receiving specialist outpatient PC increased from 8.5% (2016) to 11.2% (2020; p < .001). The onset of generalist outpatient PC moved from 106 (2016) to 93 days (2020; p < 0.001) before death, on average. The onset of specialist outpatient PC showed the reverse pattern (2016: 55 days before death; 2020: 59 days before death; p = 0.041). Conclusion Despite growing needs for PC at the end of life, the number of patients receiving outpatient PC did not increase between 2016–2020. Furthermore, specialist outpatient PC is being increasingly prescribed over generalist outpatient PC. Although the early initiation of outpatient PC has been proven valuable for the majority of people at the end of life, generalist outpatient PC was not initiated earlier in the disease trajectory over the study period, as was found to be true for specialist outpatient PC. Future studies should seek to determine how existing PC needs can be optimally met within the outpatient sector and identify factors that can support the earlier initiation of especially generalist outpatient PC. Trial registration The study “Optimal Care at the End of Life” was registered in the German Clinical Trials Register (DRKS00015108; 22 January 2019).